Moderna’s mRNA-1273 Vaccine Put to Biggest Test
The experimental vaccine, mRNA-1273, is put to its biggest test as 30,000 American volunteers roll...
Read MoreJul 29, 2020
The experimental vaccine, mRNA-1273, is put to its biggest test as 30,000 American volunteers roll...
Read MoreJul 29, 2020
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA)...
Read MoreJul 29, 2020
Telemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...
Read MoreJul 17, 2020
In the past, we as physicians have not done a great job of advocacy, and we have largely been removed from policy discussions. The emergence of physician advocacy is a relatively new phenomenon. Why? … Read Full Article...
Read MoreJul 17, 2020
[flippingbook width=”740px” height=”480px” title=”ASCO Lung Cancer...
Read MoreJul 15, 2020
“The overall take home message from the Virtual ASCO Annual Meeting this year is that...
Read MoreJul 10, 2020
Telemedicine has exploded in scope with the COVID-19 pandemic and will leave a lasting imprint on how medicine is practiced, so it is essential for physicians to understand its basic principles and the specific rules that govern...
Read MoreJul 8, 2020
Results from the phase 2 Keynote-799 trial show that addition of pembrolizumab to concurrent chemoradiation in patients with unresectable, stage IIIA-C NSCLC leads to objective response rates (ORR) that exceeded 50%, researchers...
Read MoreJul 8, 2020
Phase 1 trial shows feasibility and safety of neoadjuvant and adjuvant atezolizumab with...
Read MoreJul 8, 2020
Long-term outcomes are still poor for patients with locally advanced NSCLC with about 60% of the...
Read MoreJul 8, 2020
MET-mutations and MET-amplifications are reported in 1-6% of patients with NSCLC. In a phase 2...
Read MoreJul 8, 2020
Adjuvant osimertinib demonstrated a statistically significant and clinically meaningful benefit...
Read MoreJul 3, 2020
The latest installment of the #PWChat series centered around healthcare professionals’...
Read MoreJul 3, 2020
There’s no denying the significant impact the COVID-19 pandemic has made on medicine. “We’re...
Read MoreJul 3, 2020
There’s no denying the significant impact the COVID-19 pandemic has made on medicine. “We’re...
Read MoreJul 3, 2020
This three-part series—Part 1 in the June issue covered patient confidentiality—reviews a few topics giving physicians concern during the COVID-19 pandemic. Maintaining Office Safety PATIENTS l You retain the right to refuse a...
Read MoreJul 3, 2020
But no cost saving benefits A utilization management policy promoting hypofractionated radiotherapy is associated with the improvement of evidence-based cancer care for women with early breast cancer, researchers found. A...
Read MoreJul 3, 2020
In the past, we as physicians have not done a great job of advocacy, and we have largely been removed from policy discussions. The emergence of physician advocacy is a relatively new phenomenon. Why? … Read Full Article...
Read MoreJul 3, 2020
Adding the PARP inhibitor olaparib to bevacizumab maintenance therapy for ovarian cancer among patients who have responded to platinum-taxane chemotherapy improves outcomes regardless of when surgery took place, according to an...
Read More